Tony Eglezos
Corporate Officer/Principal chez STARPHARMA HOLDINGS LIMITED
Fortune : 21 818 $ au 31/03/2024
Profil
Tony Eglezos is currently the Vice President of Business Development at Starpharma Holdings Ltd.
Prior to this, he worked as the Senior Director of Business Development and Licensing at CSL Ltd.
from 2006 to 2013.
He also held a position as Director of Commercial Operations and Pharmaceuticals at Seqirus Pty Ltd.
Dr. Eglezos holds a doctorate from the University of Melbourne and an MBA from the University of Technology Sydney.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 267 542 ( 0,06% ) | 21 818 $ | 31/03/2024 |
Postes actifs de Tony Eglezos
| Sociétés | Poste | Début |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | 12/08/2013 |
Anciens postes connus de Tony Eglezos
| Sociétés | Poste | Fin |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | 01/08/2013 |
Seqirus Pty Ltd.
 Seqirus Pty Ltd. BiotechnologyHealth Technology Part of CSL Ltd., Seqirus Pty Ltd. is an Australian company that develops and manufactures vaccines and plasma protein biotherapies. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Formation de Tony Eglezos
| University of Melbourne | Doctorate Degree |
| University of Technology Sydney | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CSL LIMITED | Health Technology |
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Seqirus Pty Ltd.
Seqirus Pty Ltd. BiotechnologyHealth Technology Part of CSL Ltd., Seqirus Pty Ltd. is an Australian company that develops and manufactures vaccines and plasma protein biotherapies. The private company is based in Parkville, Australia. | Health Technology |
